Beacon Investment Advisory Services Inc. Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Beacon Investment Advisory Services Inc. lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,754 shares of the healthcare conglomerate’s stock after selling 264 shares during the quarter. Beacon Investment Advisory Services Inc.’s holdings in UnitedHealth Group were worth $12,719,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Bank & Trust Co acquired a new position in UnitedHealth Group in the 2nd quarter valued at about $58,000. Mather Group LLC. lifted its stake in shares of UnitedHealth Group by 8.2% in the 2nd quarter. Mather Group LLC. now owns 5,403 shares of the healthcare conglomerate’s stock valued at $2,673,000 after purchasing an additional 408 shares during the last quarter. Kingswood Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 4.5% during the 2nd quarter. Kingswood Wealth Advisors LLC now owns 15,102 shares of the healthcare conglomerate’s stock worth $7,691,000 after purchasing an additional 646 shares during the last quarter. Astoria Portfolio Advisors LLC. boosted its stake in UnitedHealth Group by 7.5% during the second quarter. Astoria Portfolio Advisors LLC. now owns 3,351 shares of the healthcare conglomerate’s stock worth $1,707,000 after buying an additional 235 shares during the period. Finally, Somerset Trust Co raised its stake in shares of UnitedHealth Group by 1.4% in the 2nd quarter. Somerset Trust Co now owns 6,299 shares of the healthcare conglomerate’s stock valued at $3,208,000 after acquiring an additional 85 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.3 %

UNH opened at $610.20 on Monday. The company has a market cap of $561.55 billion, a PE ratio of 39.75, a P/E/G ratio of 1.79 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a 50 day moving average price of $585.43 and a two-hundred day moving average price of $556.65. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.56 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Barclays boosted their target price on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Truist Financial reissued a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. TD Cowen boosted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $618.26.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.